Insulin Delivery Devices Market
PUBLISHED: 2024 ID: SMRC24806
SHARE
SHARE

Insulin Delivery Devices Market

Insulin Delivery Devices Market Forecasts to 2030 - Global Analysis By Product (Insulin Pumps, Insulin Pens, Insulin Pen Needles, Insulin Syringes, Insulin Inhalers, Insulin Jet Injectors and Other Types), Distribution Channel, End User and By Geography

4.1 (30 reviews)
4.1 (30 reviews)
Published: 2024 ID: SMRC24806

This report covers the impact of COVID-19 on this global market
Loading...

Years Covered

2021-2030

Estimated Year Value (2023)

US $14.9 BN

Projected Year Value (2030)

US $28.0 BN

CAGR (2023 - 2030)

9.4%

Regions Covered

North America, Europe, Asia Pacific, South America, and Middle East & Africa

Countries Covered

US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa

Largest Market

North America

Highest Growing Market

Asia Pacific


According to Stratistics MRC, the Global Insulin Delivery Devices Market is accounted for $14.9 billion in 2023 and is expected to reach $28.0 billion by 2030 growing at a CAGR of 9.4% during the forecast period. Insulin delivery devices are tools or systems designed to administer insulin to individuals with diabetes. They're used to regulate blood sugar levels by delivering insulin into the body. These devices come in various forms, such as insulin syringes, insulin pens, insulin pumps, and insulin jet injectors. They provide different methods for insulin administration, allowing individuals to manage their condition more effectively based on their lifestyle, preferences, and insulin needs.

According to International Diabetes Federation (IDF), the adult diabetes population in 2021 was approximately 537 million, and this number is expected to increase by 643 million in 2030. 

Market Dynamics: 

Driver: 

Rising prevalence of diabetes

The rising prevalence of diabetes has fuelled advancements in insulin delivery devices. Innovations cater to diverse needs, offering convenience and precision. From traditional syringes to advanced insulin pumps and pens, technology has revolutionized management. Smart devices integrate monitoring with delivery, enhancing patient autonomy. These devices not only improve adherence but also enhance quality of life for individuals managing diabetes, marking a significant stride in diabetes care.

Restraint:

Technical issues

Insulin delivery devices can encounter technical glitches impacting insulin administration. Malfunctions pose risks of incorrect insulin delivery, leading to hyper or hypoglycemia. Mechanical failures, like needle jams or pump blockages, necessitate immediate replacement, potentially causing inconvenience or interruptions in insulin therapy. These technical drawbacks highlight the importance of user vigilance and regular device checks to ensure seamless and safe insulin delivery. These are the factors restraining the growth of the market.

Opportunity:

Adoption of facilitative initiatives

Facilitative initiatives in insulin delivery devices have revolutionized diabetic care. Advances like smart pumps, continuous glucose monitoring integration, and user-friendly interfaces streamline management. Additionally, tech-driven features, such as automated insulin delivery algorithms, offer precise, real-time adjustments. Embracing these innovations not only empowers patients but also fosters a collaborative approach between healthcare providers and individuals managing diabetes. These are the factors propelling the growth of the market.

Threat:

High cost 

The high cost of insulin delivery devices poses significant disadvantages, primarily affecting accessibility and affordability for individuals managing diabetes. This financial burden often restricts access to essential equipment, leading to inadequate or inconsistent treatment. Limited affordability can result in compromised health outcomes due to the inability to consistently monitor blood sugar levels or administer insulin effectively. These are the aspects limiting the growth of the market.

Covid-19 Impact: 

Manufacturing slowdowns, transportation issues, and increased demand for medical supplies led to intermittent shortages and delays in availability for certain devices. The pandemic emphasized the importance of device sanitization and safety measures. Manufacturers and users paid more attention to ensuring that insulin delivery devices were properly cleaned and maintained to minimize the risk of infection.

The insulin pens segment is expected to be the largest during the forecast period

The insulin pens segment is expected to be the largest during the forecast period. ts advantages over other products. Its high adoption rate, user-friendly design, and growing consumer appeal were some of the factors that led to this segment's highest revenue share. A significant contributing aspect to the high share is the increasing emphasis that manufacturers are placing on innovation and advances. Therefore, it is anticipated that in the near future, product innovations will drive the demand for insulin pens.

The home care segment is expected to have the highest CAGR during the forecast period

The home care segment is expected to have the highest CAGR during the forecast period due to increasing awareness of diabetes care. Insulin devices used at home reduce waiting times, hospital or clinic fees, and visitation expenses. The cutting-edge gadgets, which come in the form of pens, injectors, and pumps, are compact, extremely portable, and always useful. Because of their increased usability and increased accessibility, insulin users are choosing self-care diabetes control solutions.

Region with largest share:

North America is projected to hold the largest market share during the forecast period. The market in the region has been significant, driven by various factors such as the increasing prevalence of diabetes, technological advancements in insulin delivery systems, and the growing aging population. Additionally, collaborations between healthcare providers, manufacturers, and research institutions for developing innovative insulin delivery devices have further propelled market growth in the region.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period. The market in the region has been witnessing significant growth due to various factors such as the rising prevalence of diabetes, increasing awareness about advanced insulin delivery technologies, and improving healthcare infrastructure in several countries. Moreover, government initiatives promoting diabetes management and technological advancements in insulin delivery systems contribute to the market's expansion.

Key players in the market

Some of the key players in Insulin Delivery Devices market include Abbott Laboratories, Novo Nordisk A/S, Wockhardt Ltd., Medtronic, F. Hoffmann-La Roche, Ltd., Becton, Dickinson and Company, Sanofi, Eli Lilly and Company, Biocon Ltd., Roche, Insulet Corporation, B Braun Melsungen AG, Tandem Diabetes Care, Embecta Corporation and Ypsomed AG.

Key Developments:

In June 2023, Novo Nordisk entered negotiations of acquiring BIOCORP, which specialized in the design and development of medical devices. This was done for the development of FlexTouch Pen with Mallya, an add-on Bluetooth device.

In Feb 2023, Lilly and IABL, the largest healthcare provider collaborated to provide high-quality and affordable insulin in Bangladesh.

Types Covered:
• Insulin Pumps 
• Insulin Pens 
• Insulin Pen Needles 
• Insulin Syringes
• Insulin Inhalers
• Insulin Jet Injectors
• Other Types

Distribution Channels Covered:
• Online Sales
• Hospital Pharmacies
• Retail Pharmacies 

End Users Covered:
• Homecare
• Clinics
• Other End Users 

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan        
o China        
o India        
o Australia  
o New Zealand
o South Korea
o Rest of Asia Pacific    
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa 
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings: 
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary      
        
2 Preface       

 2.1 Abstract      
 2.2 Stake Holders     
 2.3 Research Scope     
 2.4 Research Methodology    
  2.4.1 Data Mining    
  2.4.2 Data Analysis    
  2.4.3 Data Validation    
  2.4.4 Research Approach    
 2.5 Research Sources     
  2.5.1 Primary Research Sources   
  2.5.2 Secondary Research Sources   
  2.5.3 Assumptions    
        
3 Market Trend Analysis     
 3.1 Introduction     
 3.2 Drivers      
 3.3 Restraints     
 3.4 Opportunities     
 3.5 Threats      
 3.6 Product Analysis     
 3.7 End User Analysis     
 3.8 Emerging Markets     
 3.9 Impact of Covid-19     
        
4 Porters Five Force Analysis     

 4.1 Bargaining power of suppliers    
 4.2 Bargaining power of buyers    
 4.3 Threat of substitutes    
 4.4 Threat of new entrants    
 4.5 Competitive rivalry     
        
5 Global Insulin Delivery Devices Market, By Product   
 5.1 Introduction     
 5.2 Insulin Pumps     
  5.2.1 Tubeless      
  5.2.2 Tethered     
 5.3 Insulin Pens     
  5.3.1 Reusable     
  5.3.2 Disposable     
 5.4 Insulin Pen Needles    
  5.4.1 Safety      
  5.4.2 Standard      
 5.5 Insulin Syringes     
 5.6 Insulin Inhalers     
 5.7 Insulin Jet Injectors     
 5.8 Other Types     
        
6 Global Insulin Delivery Devices Market, By Distribution Channel 
 6.1 Introduction     
 6.2 Online Sales     
 6.3 Hospital Pharmacies    
 6.4 Retail Pharmacies     
        
7 Global Insulin Delivery Devices Market, By End User  
 7.1 Introduction     
 7.2 Homecare     
 7.3 Clinics      
 7.4 Other End Users     
        
8 Global Insulin Delivery Devices Market, By Geography  
 8.1 Introduction     
 8.2 North America     
  8.2.1 US     
  8.2.2 Canada     
  8.2.3 Mexico     
 8.3 Europe      
  8.3.1 Germany     
  8.3.2 UK     
  8.3.3 Italy     
  8.3.4 France     
  8.3.5 Spain     
  8.3.6 Rest of Europe    
 8.4 Asia Pacific     
  8.4.1 Japan     
  8.4.2 China     
  8.4.3 India     
  8.4.4 Australia     
  8.4.5 New Zealand    
  8.4.6 South Korea    
  8.4.7 Rest of Asia Pacific    
 8.5 South America     
  8.5.1 Argentina    
  8.5.2 Brazil     
  8.5.3 Chile     
  8.5.4 Rest of South America   
 8.6 Middle East & Africa    
  8.6.1 Saudi Arabia    
  8.6.2 UAE     
  8.6.3 Qatar     
  8.6.4 South Africa    
  8.6.5 Rest of Middle East & Africa   
        
9 Key Developments      
 9.1 Agreements, Partnerships, Collaborations and Joint Ventures 
 9.2 Acquisitions & Mergers    
 9.3 New Product Launch    
 9.4 Expansions     
 9.5 Other Key Strategies    
        
10 Company Profiling      
 10.1 Abbott Laboratories     
 10.2 Novo Nordisk A/S     
 10.3 Wockhardt Ltd.     
 10.4 Medtronic     
 10.5 F. Hoffmann-La Roche, Ltd.    
 10.6 Becton, Dickinson and Company   
 10.7 Sanofi      
 10.8 Eli Lilly and Company    
 10.9 Biocon Ltd.     
 10.10 Roche      
 10.11 Insulet Corporation     
 10.12 B Braun Melsungen AG    
 10.13 Tandem Diabetes Care    
 10.14 Embecta Corporation    
 10.15 Ypsomed AG     
        
List of Tables       
1 Global Insulin Delivery Devices Market Outlook, By Region (2021-2030) ($MN)
2 Global Insulin Delivery Devices Market Outlook, By Product (2021-2030) ($MN)
3 Global Insulin Delivery Devices Market Outlook, By Insulin Pumps (2021-2030) ($MN)
4 Global Insulin Delivery Devices Market Outlook, By Tubeless  (2021-2030) ($MN)
5 Global Insulin Delivery Devices Market Outlook, By Tethered  (2021-2030) ($MN)
6 Global Insulin Delivery Devices Market Outlook, By Insulin Pens (2021-2030) ($MN)
7 Global Insulin Delivery Devices Market Outlook, By Reusable  (2021-2030) ($MN)
8 Global Insulin Delivery Devices Market Outlook, By Disposable  (2021-2030) ($MN)
9 Global Insulin Delivery Devices Market Outlook, By Insulin Pen Needles (2021-2030) ($MN)
10 Global Insulin Delivery Devices Market Outlook, By Safety  (2021-2030) ($MN)
11 Global Insulin Delivery Devices Market Outlook, By Standard  (2021-2030) ($MN)
12 Global Insulin Delivery Devices Market Outlook, By Insulin Syringes (2021-2030) ($MN)
13 Global Insulin Delivery Devices Market Outlook, By Insulin Inhalers (2021-2030) ($MN)
14 Global Insulin Delivery Devices Market Outlook, By Insulin Jet Injectors (2021-2030) ($MN)
15 Global Insulin Delivery Devices Market Outlook, By Other Types (2021-2030) ($MN)
16 Global Insulin Delivery Devices Market Outlook, By Distribution Channel (2021-2030) ($MN)
17 Global Insulin Delivery Devices Market Outlook, By Online Sales (2021-2030) ($MN)
18 Global Insulin Delivery Devices Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
19 Global Insulin Delivery Devices Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
20 Global Insulin Delivery Devices Market Outlook, By End User (2021-2030) ($MN)
21 Global Insulin Delivery Devices Market Outlook, By Homecare (2021-2030) ($MN)
22 Global Insulin Delivery Devices Market Outlook, By Clinics (2021-2030) ($MN)
23 Global Insulin Delivery Devices Market Outlook, By Other End Users (2021-2030) ($MN)
24 North America Insulin Delivery Devices Market Outlook, By Country (2021-2030) ($MN)
25 North America Insulin Delivery Devices Market Outlook, By Product (2021-2030) ($MN)
26 North America Insulin Delivery Devices Market Outlook, By Insulin Pumps (2021-2030) ($MN)
27 North America Insulin Delivery Devices Market Outlook, By Tubeless  (2021-2030) ($MN)
28 North America Insulin Delivery Devices Market Outlook, By Tethered  (2021-2030) ($MN)
29 North America Insulin Delivery Devices Market Outlook, By Insulin Pens (2021-2030) ($MN)
30 North America Insulin Delivery Devices Market Outlook, By Reusable  (2021-2030) ($MN)
31 North America Insulin Delivery Devices Market Outlook, By Disposable  (2021-2030) ($MN)
32 North America Insulin Delivery Devices Market Outlook, By Insulin Pen Needles (2021-2030) ($MN)
33 North America Insulin Delivery Devices Market Outlook, By Safety  (2021-2030) ($MN)
34 North America Insulin Delivery Devices Market Outlook, By Standard  (2021-2030) ($MN)
35 North America Insulin Delivery Devices Market Outlook, By Insulin Syringes (2021-2030) ($MN)
36 North America Insulin Delivery Devices Market Outlook, By Insulin Inhalers (2021-2030) ($MN)
37 North America Insulin Delivery Devices Market Outlook, By Insulin Jet Injectors (2021-2030) ($MN)
38 North America Insulin Delivery Devices Market Outlook, By Other Types (2021-2030) ($MN)
39 North America Insulin Delivery Devices Market Outlook, By Distribution Channel (2021-2030) ($MN)
40 North America Insulin Delivery Devices Market Outlook, By Online Sales (2021-2030) ($MN)
41 North America Insulin Delivery Devices Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
42 North America Insulin Delivery Devices Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
43 North America Insulin Delivery Devices Market Outlook, By End User (2021-2030) ($MN)
44 North America Insulin Delivery Devices Market Outlook, By Homecare (2021-2030) ($MN)
45 North America Insulin Delivery Devices Market Outlook, By Clinics (2021-2030) ($MN)
46 North America Insulin Delivery Devices Market Outlook, By Other End Users (2021-2030) ($MN)
47 Europe Insulin Delivery Devices Market Outlook, By Country (2021-2030) ($MN)
48 Europe Insulin Delivery Devices Market Outlook, By Product (2021-2030) ($MN)
49 Europe Insulin Delivery Devices Market Outlook, By Insulin Pumps (2021-2030) ($MN)
50 Europe Insulin Delivery Devices Market Outlook, By Tubeless  (2021-2030) ($MN)
51 Europe Insulin Delivery Devices Market Outlook, By Tethered  (2021-2030) ($MN)
52 Europe Insulin Delivery Devices Market Outlook, By Insulin Pens (2021-2030) ($MN)
53 Europe Insulin Delivery Devices Market Outlook, By Reusable  (2021-2030) ($MN)
54 Europe Insulin Delivery Devices Market Outlook, By Disposable  (2021-2030) ($MN)
55 Europe Insulin Delivery Devices Market Outlook, By Insulin Pen Needles (2021-2030) ($MN)
56 Europe Insulin Delivery Devices Market Outlook, By Safety  (2021-2030) ($MN)
57 Europe Insulin Delivery Devices Market Outlook, By Standard  (2021-2030) ($MN)
58 Europe Insulin Delivery Devices Market Outlook, By Insulin Syringes (2021-2030) ($MN)
59 Europe Insulin Delivery Devices Market Outlook, By Insulin Inhalers (2021-2030) ($MN)
60 Europe Insulin Delivery Devices Market Outlook, By Insulin Jet Injectors (2021-2030) ($MN)
61 Europe Insulin Delivery Devices Market Outlook, By Other Types (2021-2030) ($MN)
62 Europe Insulin Delivery Devices Market Outlook, By Distribution Channel (2021-2030) ($MN)
63 Europe Insulin Delivery Devices Market Outlook, By Online Sales (2021-2030) ($MN)
64 Europe Insulin Delivery Devices Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
65 Europe Insulin Delivery Devices Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
66 Europe Insulin Delivery Devices Market Outlook, By End User (2021-2030) ($MN)
67 Europe Insulin Delivery Devices Market Outlook, By Homecare (2021-2030) ($MN)
68 Europe Insulin Delivery Devices Market Outlook, By Clinics (2021-2030) ($MN)
69 Europe Insulin Delivery Devices Market Outlook, By Other End Users (2021-2030) ($MN)
70 Asia Pacific Insulin Delivery Devices Market Outlook, By Country (2021-2030) ($MN)
71 Asia Pacific Insulin Delivery Devices Market Outlook, By Product (2021-2030) ($MN)
72 Asia Pacific Insulin Delivery Devices Market Outlook, By Insulin Pumps (2021-2030) ($MN)
73 Asia Pacific Insulin Delivery Devices Market Outlook, By Tubeless  (2021-2030) ($MN)
74 Asia Pacific Insulin Delivery Devices Market Outlook, By Tethered  (2021-2030) ($MN)
75 Asia Pacific Insulin Delivery Devices Market Outlook, By Insulin Pens (2021-2030) ($MN)
76 Asia Pacific Insulin Delivery Devices Market Outlook, By Reusable  (2021-2030) ($MN)
77 Asia Pacific Insulin Delivery Devices Market Outlook, By Disposable  (2021-2030) ($MN)
78 Asia Pacific Insulin Delivery Devices Market Outlook, By Insulin Pen Needles (2021-2030) ($MN)
79 Asia Pacific Insulin Delivery Devices Market Outlook, By Safety  (2021-2030) ($MN)
80 Asia Pacific Insulin Delivery Devices Market Outlook, By Standard  (2021-2030) ($MN)
81 Asia Pacific Insulin Delivery Devices Market Outlook, By Insulin Syringes (2021-2030) ($MN)
82 Asia Pacific Insulin Delivery Devices Market Outlook, By Insulin Inhalers (2021-2030) ($MN)
83 Asia Pacific Insulin Delivery Devices Market Outlook, By Insulin Jet Injectors (2021-2030) ($MN)
84 Asia Pacific Insulin Delivery Devices Market Outlook, By Other Types (2021-2030) ($MN)
85 Asia Pacific Insulin Delivery Devices Market Outlook, By Distribution Channel (2021-2030) ($MN)
86 Asia Pacific Insulin Delivery Devices Market Outlook, By Online Sales (2021-2030) ($MN)
87 Asia Pacific Insulin Delivery Devices Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
88 Asia Pacific Insulin Delivery Devices Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
89 Asia Pacific Insulin Delivery Devices Market Outlook, By End User (2021-2030) ($MN)
90 Asia Pacific Insulin Delivery Devices Market Outlook, By Homecare (2021-2030) ($MN)
91 Asia Pacific Insulin Delivery Devices Market Outlook, By Clinics (2021-2030) ($MN)
92 Asia Pacific Insulin Delivery Devices Market Outlook, By Other End Users (2021-2030) ($MN)
93 South America Insulin Delivery Devices Market Outlook, By Country (2021-2030) ($MN)
94 South America Insulin Delivery Devices Market Outlook, By Product (2021-2030) ($MN)
95 South America Insulin Delivery Devices Market Outlook, By Insulin Pumps (2021-2030) ($MN)
96 South America Insulin Delivery Devices Market Outlook, By Tubeless  (2021-2030) ($MN)
97 South America Insulin Delivery Devices Market Outlook, By Tethered  (2021-2030) ($MN)
98 South America Insulin Delivery Devices Market Outlook, By Insulin Pens (2021-2030) ($MN)
99 South America Insulin Delivery Devices Market Outlook, By Reusable  (2021-2030) ($MN)
100 South America Insulin Delivery Devices Market Outlook, By Disposable  (2021-2030) ($MN)
101 South America Insulin Delivery Devices Market Outlook, By Insulin Pen Needles (2021-2030) ($MN)
102 South America Insulin Delivery Devices Market Outlook, By Safety  (2021-2030) ($MN)
103 South America Insulin Delivery Devices Market Outlook, By Standard  (2021-2030) ($MN)
104 South America Insulin Delivery Devices Market Outlook, By Insulin Syringes (2021-2030) ($MN)
105 South America Insulin Delivery Devices Market Outlook, By Insulin Inhalers (2021-2030) ($MN)
106 South America Insulin Delivery Devices Market Outlook, By Insulin Jet Injectors (2021-2030) ($MN)
107 South America Insulin Delivery Devices Market Outlook, By Other Types (2021-2030) ($MN)
108 South America Insulin Delivery Devices Market Outlook, By Distribution Channel (2021-2030) ($MN)
109 South America Insulin Delivery Devices Market Outlook, By Online Sales (2021-2030) ($MN)
110 South America Insulin Delivery Devices Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
111 South America Insulin Delivery Devices Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
112 South America Insulin Delivery Devices Market Outlook, By End User (2021-2030) ($MN)
113 South America Insulin Delivery Devices Market Outlook, By Homecare (2021-2030) ($MN)
114 South America Insulin Delivery Devices Market Outlook, By Clinics (2021-2030) ($MN)
115 South America Insulin Delivery Devices Market Outlook, By Other End Users (2021-2030) ($MN)
116 Middle East & Africa Insulin Delivery Devices Market Outlook, By Country (2021-2030) ($MN)
117 Middle East & Africa Insulin Delivery Devices Market Outlook, By Product (2021-2030) ($MN)
118 Middle East & Africa Insulin Delivery Devices Market Outlook, By Insulin Pumps (2021-2030) ($MN)
119 Middle East & Africa Insulin Delivery Devices Market Outlook, By Tubeless  (2021-2030) ($MN)
120 Middle East & Africa Insulin Delivery Devices Market Outlook, By Tethered  (2021-2030) ($MN)
121 Middle East & Africa Insulin Delivery Devices Market Outlook, By Insulin Pens (2021-2030) ($MN)
122 Middle East & Africa Insulin Delivery Devices Market Outlook, By Reusable  (2021-2030) ($MN)
123 Middle East & Africa Insulin Delivery Devices Market Outlook, By Disposable  (2021-2030) ($MN)
124 Middle East & Africa Insulin Delivery Devices Market Outlook, By Insulin Pen Needles (2021-2030) ($MN)
125 Middle East & Africa Insulin Delivery Devices Market Outlook, By Safety  (2021-2030) ($MN)
126 Middle East & Africa Insulin Delivery Devices Market Outlook, By Standard  (2021-2030) ($MN)
127 Middle East & Africa Insulin Delivery Devices Market Outlook, By Insulin Syringes (2021-2030) ($MN)
128 Middle East & Africa Insulin Delivery Devices Market Outlook, By Insulin Inhalers (2021-2030) ($MN)
129 Middle East & Africa Insulin Delivery Devices Market Outlook, By Insulin Jet Injectors (2021-2030) ($MN)
130 Middle East & Africa Insulin Delivery Devices Market Outlook, By Other Types (2021-2030) ($MN)
131 Middle East & Africa Insulin Delivery Devices Market Outlook, By Distribution Channel (2021-2030) ($MN)
132 Middle East & Africa Insulin Delivery Devices Market Outlook, By Online Sales (2021-2030) ($MN)
133 Middle East & Africa Insulin Delivery Devices Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
134 Middle East & Africa Insulin Delivery Devices Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
135 Middle East & Africa Insulin Delivery Devices Market Outlook, By End User (2021-2030) ($MN)
136 Middle East & Africa Insulin Delivery Devices Market Outlook, By Homecare (2021-2030) ($MN)
137 Middle East & Africa Insulin Delivery Devices Market Outlook, By Clinics (2021-2030) ($MN)
138 Middle East & Africa Insulin Delivery Devices Market Outlook, By Other End Users (2021-2030) ($MN)

List of Figures

RESEARCH METHODOLOGY


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.


Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.


For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials